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Molecular dockingisthemostpracticalapproachtoleverageproteinstructureforliganddiscovery,but
the technique retains important liabilities that make it challenging to deploy on a large scale. We have
therefore created an expert system, DOCK Blaster, to investigate the feasibility of full automation. The
method requires a PDB code, sometimes with a ligand structure, and from that alone can launch a full
screenoflargelibraries.Acriticalfeatureisself-assessment,whichestimatestheanticipatedreliabilityof
the automated screening results using pose fidelity and enrichment. Against common benchmarks,
DOCK Blaster recapitulates the crystal ligand pose within 2 A ˚ rmsd 50-60% of the time; inferior to an
expert, but respectrable. Half the time the ligand also ranked among the top 5% of 100 physically
matched decoys chosen on the fly. Further tests were undertaken culminating in a study of 7755 eligible
PDB structures. In 1398 cases, the redocked ligand ranked in the top 5% of 100 property-matched
decoys while also posing within 2 A ˚ rmsd, suggesting that unsupervised prospective docking is viable.
DOCK Blaster is available at http://blaster.docking.org.
Introduction
Molecular docking has had important recent successes
1-12
andisnowwidelyusedinindustryandacademia.Butwhereas
other techniques in computational biology such as homology
modeling
13 and sequence database searching
14 have been
successfully deployed on a proteomic scale, docking has
remained manually intensive. Docking programs are challen-
gingtouse,withmanyparameterstobechosen,fileformatsto
be manipulated, and decisions to be made at both the pre-
paration and analysis stages. Even in expert hands, there are
targets for which docking simply fails to recapitulate experi-
mentally known binding information. These barriers to entry
have diminished the impact of the technique by making it less
accessibletobiologicallyorientednonexpertsandchallenging
even for specialists to deploy on a large scale.
One approach to make docking accessible to more investi-
gators, and to make it more systematic even for experts, is to
automate it. We have therefore investigated anexpertsystem,
DOCK Blaster, which aims to emulate experts at all stages of
the docking process. Ideally, DOCK Blaster could start from
aslittleas aPDB
a codeandfromthatlaunchafullscreenofa
largecompoundlibrarytofindnovelligands.Todosoitmust
overcome substantial challenges in preparing a target site for
docking, it must explore variation in the sampling and often
scoring, and it must conduct control calculations to judge the
quality of the screen. For instance, the automated procedure
must recognize common cofactors, metals, post-translational
modifications, and solutes to identify the ligand and separate
it from the receptor. Second, “hotspots” for dockingmust be
identified for a wide range of binding site sizes and shapes.
Third, parameters must be assigned to receptor atoms in a
robustway that cancopenotonlywithcofactors, metals,and
post-translational modifications but also with unforeseen
moieties for which no dictionary is available. Because an
expert would normally experiment with several variations in
samplingandscoring,anautomatedsystemshoulddosoalso,
picking the best parameters to use for a full database screen.
Finally, the entire docking process should be integrated from
end toend so astorecover fromsimpleproblems, continue as
far as possible, and end gracefully should an unrecoverable
error occur.
Here we describe DOCK Blaster, a fully automated dock-
ing systemincluding self-assessment.Themethod is testedfor
pose-fidelity,theabilitytoreproduceexperimentallyobserved
poses within some tolerance limit, and enrichment, the ability
to enrich actives from among a database of decoys, where a
decoy is a member of the database that does not bind to the
target. We have used three of the most common benchmark-
ing sets: the Astex-85 set,
7 having 85 high-quality crystal
structures of therapeutically relevant targets and “drug-like”
ligands, the GOLD-114 benchmark,
15 derived from the most
widely used docking benchmarks,
16,17 and the DUD set,
27 38
protein targets for which sets of annotated actives and corre-
sponding property-matched decoys are available for each
target. Property-matched decoys have similar physical prop-
erties but different topologies that one would not expect
should be recognized by the protein, a key requirement for a
high score. Whereas we find that the automated method is
typicallyoutperformedbyanexpert,itsperformanceisnever-
theless respectable.
*To whom correspondence should be addressed. Phone: 415-514-
4127. Fax: 415-514-4260. E-mail: jji@cgl.ucsf.edu.
aAbbreviations:rmsd,rootmeansquareddeviation;SAR,structure-
activity relationship; PDB, Protein Data Bank; ROC, receiver operator
characteristic.Article Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 5713
In principle, such an automated procedure could bring
docking to a much larger community and could be used to
explore targets on a proteomic scale. For the first goal to
providemoregoodthanharm,itisimportanttoprovidewhat
mayoftenbena¨ıveuserswithanautomatedself-assessmentof
the docking results. We investigate methods to do so using
pose fidelity and enrichment based on a single observed
crystallographic ligand. To investigate the plausibility of the
secondgoal,wedescribeheredockingscreenson7755protein
targets where each screen is performed against a feasibility
library of 100 molecules.
Methods
DOCKBlasteriscomposedof anexpertsystemengineand
aweb-enableduserinterface(Figure1).Thedockingprogram
used is DOCK 3.5.54,
28,29 a version of UCSF DOCK. The
DOCKBlasterpipelineiscomposedofsixmodules(Figure2):
(a) the parser, which identifies the receptor and ligand from a
PDB file, (b) the scrutinizer, which attempts to correct for
problems, such as incomplete or disordered residues on the
receptor, (c) the preparer, which protonates the receptor,
calculates “hot spots” and scoring grids, assigns atomic para-
meters, including these for cofactors, post-translational mod-
ificationsandmetals,andpreparestheligand,decoys,andany
activesandinactivesfordocking,(d)thecalibrator,whichuses
supplied data to assess docking performance and suggests
optimal docking parameters, (e) the docker,w h i c hm a n a g e sa
full database screen on the computer cluster, and (f) the
assessor, which prepares reports to interpret database screen-
ing results. We take up each module in turn.
a. The Parser. This expert system starts with a PDB code.
The file is retrieved directly from the PDB Web site with no
preprocessing. The Parser uses dictionaries of common
cofactors,ions,post-translationalmodifications,andsolutes
to identify and separate the ligand from the receptor. If the
ligand itself is a common solute or cofactor, a three letter
code of the ligand must be specified. If more than one ligand
is available, the Parser asks the user to pick one. In fully
automated screens, such ambiguity stops the procedure. If
no ligand can be identified, the Parser also halts the calcula-
tion with an error message. A future version may use auto-
matic bindingsiteidentificationsoftware
30-32toidentifythe
binding site in this case. The Parser produces files that are
readytobeusedbythescrutinizerinthenextstepandmaybe
accessed online at http://blaster.docking.org/parser.shtml.
b. The Scrutinizer. The Scrutinizer takes as input a target
structure and a specification of the binding site, which may
be either a docked ligand in mol2 format or atoms in or near
the binding site in PDB format. The Scrutinizer checks that
the receptor and ligand are properly formatted, and that at
least one atom of the ligand is within a binding site on the
protein. This step also attempts to flesh out incomplete
residues and pick the first of any disorder models present.
The Scrutinizer can take input directly from the parser
(module a, above) or from the job preparation page, http://
blaster.docking.org/start.shtml.
c. The Preparer. The Preparer is an expert system that
performs actions necessary before docking can begin. This
includes maturing the receptor model by removal of ordered
water molecules, protonation of receptor atoms to a united
atom model, and assignment of AMBER atom types
33
including to metals, cofactors, and post-translational mod-
ifications that are effectively part of the receptor. Subse-
quently docking “hot spots” are calculated by sphgen,
34
while van der Waals and electrostatics scoring grids are
calculated by chemgrid
35 and Delphi,
36 respectively. To
correct for ligand desolvation, solvmap
37 is used to calculate
a solvent occlusion grid. To prepare a dockable database of
the ligand and any actives and inactive controls, the PDB
format ligand is converted to SMILES using OpenEye’s
OEChem
38 to eliminate bias. The molecule is then processed
using the standard ZINC protocol,
39 which aims to enumer-
ate all physiologically relevant protonated and tautomeric
forms of the molecule. In parallel, property-matched decoys
for the ligand are found from ZINC using the DUD proto-
cols
27,40 for enrichment and ranking.
Figure 1. TheDOCKBlasterwebinterface,availablestartingfrom
http://blaster.docking.org/.
Figure 2. DOCK Blaster pipeline schematic. Left: two starting
points for DOCK Blaster. Center: six main modules of the auto-
matic docking pipeline. Right: four places in which automatic
docking can fail.5714 Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 Irwin et al.
Four parameter sets are evaluated by performing sam-
pling and scoring each in two different ways. DOCK Blaster
uses two different sampling schemes called “coarser” and
“finer” to sample fewer or more ligand orientations by
adjusting the bins used to generate initial orientations. The
“coarser” scheme uses 45 “hot spots” and wider bins and
generallyrunssomewhatfaster,whereas“finer”uses55“hot
spots”, narrower bins, and is often slower. Two scoring
schemes called “polarized” and “normal” are also used.
The “normal” scheme uses standard AMBER 94 partial
atomic charges on the protein, while “polarized” increases
thedipolesonselectedpolaratomsinresidueswithin3.5A ˚ of
the crystallographic ligand without changing the net charge.
In prospective studies involving experimental testing of
novel inhibitors, we have found such limited polarization
useful.
41-44 Each ligand configuration that passes a rapid
steric fit filter is scored for electrostatic and van der Waals
complementarity and adjusted for partial ligand desolvation
due to solvent occlusion.
37 The high-scoring ligand confor-
mation is minimized with 100 steps of simplex rigid-body
minimization. More details of these schemes and other
technical details may be found on the DOCK Blaster docu-
mentation Web site, http://disi.docking.org/DOCK_Bla-
ster:Technical_Details.
d. The Calibrator. This subsystem evaluates how well
docking works as judged by pose fidelity to the crystal
structure and by enrichment versus decoys. In doing so, this
tool selects the best docking parameters for a full database
screen. It first redocks the ligand using all four docking
parametersets.Itevaluatesposefidelityusingthermsdofall
non-H atoms to the crystallographic pose and calculates the
rank of the redocked ligand among the 100 property-
matched decoys, which are also docked using all four dock-
ing parameter sets. If actives and inactives were supplied, as
is the case for the DUD benchmark, these are also docked
and ROC plots are calculated.
A concise calibration docking report allows users to judge
whichparametrization,ifany,isbestforprospectivedocking
(Figure 3). Outcomes are color coded to indicate successful
(in green), unsuccessful (in red), and borderline (in yellow)
results.Particularlyforborderlinecases,theusermaywishto
inspect the scores and poses of each ligand and decoy before
selecting the best parametrization for prospective docking.
e.TheDocker.Thismodulescreens(potentiallyverylarge)
ZINC subsets on a computer cluster. It is normally only
invoked after the calibrator has established that docking is
viable. The most successful set of docking parameters from
the calibration phase is selected and used. The Docker
manages the screen across multiple CPUs, combining the
results when the entire library has been searched.
f. The Assessor. When database docking is complete, the
Assessor prepares reports including full purchasing informa-
tion, annotation of physical properties, annotation of known
activities derived from public data sources, and similarity to
annotated compounds, other top hits, and other purchasable
compounds. Docked structures may be viewed in the context
ofthebindingsiteusingPyMol,
45Chimera
46orJMol.
47These
reports may be browsed online or downloaded in tab-delim-
ited format for processing by analysis software such as Excel.
DOCK Blaster is accessible via a web-based interface at
http://blaster.docking.org(Figure1).Itishostedonacluster
of 700 CPU cores managed using the Sun Grid Engine with
access to 30 terabytes of RAID-6 storage. DOCK Blaster is
integrated with ZINC,
39 a public access database of com-
merciallyavailablecompoundsforlibraryscreening,andthe
DUD Decoy Maker,
27,40 which are also accessible sepa-
rately. We do preserve the results of some screens, which
we may use for methods development and analyses.
DOCKBlasterwastestedusingligand-boundcrystalstruc-
tures from the PDB,
48 including some of the most widely
used benchmarking standards: Astex-85,
7 GOLD-114
15,a n d
DUD-38
27 (release 2, Oct 2006). We have used only the 38
structuresinDUDforwhichaligand-boundcrystalstructure
is available. We have used only postremediation
49 PDB
structures for which a single small (<500 Da) organic ligand
is bound, having 2.5 A ˚ resolution or better, and no poly-
nucleotides.
Results
DOCK Blaster is a new tool for automatic docking and is
available for free anonymous public access at http://blaster.
docking.org. DOCK Blaster can start from the structure of a
target and a specification of the binding site or simply from a
PDB code in many cases. To assess the performance of our
automatic high throughput docking procedure retrospec-
tively, we turned to common benchmarks in the field: Astex-
85,
7GOLD-114,
15andDUD-38.
27Webeganbyretrievingthe
files directly from the remediated
49 PDB and used the parser
to automatically separate the ligand from the receptor. In all
but a few cases, the parser succeeded well enough in this task
to proceed to docking (Supporting Information Table S1).
Occasionallythe ligandcould not beidentifiedautomatically.
One reason was that the ligand was a common solute such as
citrate. These could be rescued by simply specifying the three
letter code of the ligand to the parser. The average total CPU
time per target, from preparation to docking the ligand and
its 100 decoys to final analysis of the results, all automated,
was 92 min.
Astex-85 Benchmarking. We began by using DOCK Blas-
tertoautomaticallydocktotargetsintheAstex-85set.
7Inall
but one case, the ligand was automatically separated from
the protein starting from the PDB code alone (Supporting
Information Table S1). For 1LF7, we were required to
specify the ligand (citrate, CIT) because it is a common
solute. Of the 84 jobs started automatically, 83 finished
normally and produced a docked pose and score for the
ligand and its decoys (Supporting Information Table S2).
One ligand failed during conversion to SMILES (1U4D).
We asked how well automatic docking could recapitulate
the crystal structure using each of four docking parameter
sets. Of the 83 protein-ligand pairs that yielded a docked
ligand score, 51 were within 2 A ˚ rmsd ofthe crystal structure
Figure 3. Calibration docking report, containing pose fidelity (A ˚ ,
rmsd) and enrichment (% rank) of the redocked crystallographic
ligand compared to 100 property matched decoys using four para-
metrizations,separatedbyaforwardslash(/)ineachcell.Successful
runs are in green, unsuccessful ones in red, and marginal ones in
yellow.Article Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 5715
(SupportingInformationTableS2,andhttp://data.docking.
org/2009/AstexTables.doc). Some parametrization schemes
were more successful than others. The best was “finer/
polarized” with 49 successes, followed by “finer/normal”
with46,“coarser/polarized”with37,andtheleast successful
being “coarser/normal” with 34 successes. The “finer”
schemes having more spheres generally outperformed the
“coarser” schemes, although this was not always true. The
polarized dipoles in the electrostatics of “polarized” were
slightly more successful than the “normal” scheme having
standard AMBER94 charges on the protein.
For the 51 protein-ligand complexes docked within 2 A ˚
rmsd of the crystal pose, we then asked how well the
redocked crystallographic ligand ranked compared to
around 100 property-matched decoys (Tables 1 and 2 and
http://data.docking.org/2009/AstexTables.doc). The well-
posed ligand also ranked in the top 5% of the property
matcheddecoysin29cases,suggestingthatthesearesuitable
for automatic prospective docking. Just beyond the 2 A ˚
cutoff, there were 11 cases in which the ligand posed close,
within 3 A ˚ , and a further 20 cases where the ligand never got
even as close as 3 A ˚ rmsd to the crystallographic ligand.
For 18 targets, the results were excellent regardless of
which docking parameter set was chosen; we could find no
common theme among the targets to which to attribute this
good fortune (Figure 4). There were three nuclear receptors
(1M2Z, 1N46, 1SQN), six kinases (1KE5, 1OPK, 1YWR,
1V4S, 1PMN, 1T46), and seven other enzymes (1HWI,
1OF6, 1LPZ, 1Q4G, 1JLA, 1R9O, 1VCJ). There was no
obvious pattern in the physical or chemical properties of the
ligands to explain why these targets worked so reliably. We
did notice some patterns among the less successful docking
calculations, however.
Five targets achieved good poses with all parametriza-
tions, yet the ligand never ranked well (Figure 5 and http://
data.docking.org/2009/AstexTables.doc, class 4): 1IA1,
1J3J, 1TZ8, 1XM6, and 1XOQ. These cases are interesting
because pose fidelity is often used as a metric for docking
success. Poor ranks despite good poses can arise when either
the ligand scores unexpectedly poorly or the decoys score
unexpectedly well. For instance, many decoys for 1IA1,
dihydrofolate reductase (DHFR), contained guanidinium
and other groups that might well bind to DHFR and in turn
received excellent scores. Because the ligands looked compe-
titive to us, we attribute the failure to achieve a good rank as
being due to highly competitive decoys rather than a failure
of the ligand itself, as it also received a good score. Future
work will investigate whether the decoy selection procedure
mightbeimprovedtoremoveviable-lookingligandsthatare
not currently eliminated byour fingerprint-based dissimilar-
ity metric.
Failure to achieve even a good pose against perhaps
20-30% of targets is common in docking studies, so we
were not much surprised to note 31 targets where the ligand
did not dock even close (within 3 A ˚ rmsd) to a satisfactory
pose (Figure 6 and http://data.docking.org/2009/AstexTa-
bles.doc, class 6). Many of these pose fidelity failures could
be attributed to one of four common causes: (a) insufficient
conformational sampling of the ligand, particularly of ali-
phatic ring puckering, (b) symmetric or pseudosymmetric
molecule, (c) critical missing water molecules, and (d) ligand
pose dominated by electronic (orbital) effects. These issues
are common to all docking methods and protocols and are
therefore expected for this study. In the scripted, automatic
context of DOCK Blaster, some of these problems could be
addressed, for instance by using a rescoring method to allow
forrelaxationofringpuckeringor anapproachthatsamples
explicit water molecule positions.
50 Other failures, such as
the plausible reversed docking pose of a pseudosymmetrical
molecule in1YV3, couldbebetteraddressedusinga density-
basedpose-assessmentmethod.
51Somefailuresareprobably
simply beyond the capabilities of an orbital-na¨ıve method
like DOCK, such as 1P2Y, a P450, where the ligand pose
appears to be under electronic rather than steric control.
Whereas some of these failures may be addressed by im-
provements in the protocol, we worry about a tendency to
buildintoomuch“expertise”thatleadstooverfitting.Some
of these problem targets will likely remain beyond the
capability of full automation, at least in the near term.
With four parameter sets to choose from, we wondered
whether one of them was more successful at achieving good
pose fidelity than the others. To answer this, we plotted the
frequency and cumulative frequency of pose fidelity for the
best parameter set for each case (Figure 7) and also for each
parameter set separately (Supporting Information Figure S1).
W ef o u n dt h a ta l lp a r a m e t e rs e t sa c h i e v e dap o s ew i t h i n2A ˚
rmsd at least 50% of the time. The “finer” schemes performed
slightlybetterat60%.Thesegraphsconfirmthatallparameter
sets are roughly comparable at achieving good ligand poses,
that each is best some of the time, and none of the parame-
trizations is either much better or much worse than average.
Wewonderedwhetherbetterposefidelitycouldbeusedto
predict rank. If it were, good pose fidelity as measured by
rmsdcouldbeusedtoselectthebestdockingparameters.We
plotted pose fidelity (A ˚ , rmsd) versus rank using the para-
metersthatledtothebestposefidelityineachcase(Figure8)
and also for each parameter set separately (Supporting
Information Figure S2). Poor pose fidelity was generally
associated with poorly ranked compounds, although there
was one notable exception, beta II tryptase (2BM2), where
the ligand docked backward but still managed to get a good
score compared to its decoys. However, good pose fidelity
was entirely uncorrelated with rank, regardless of which
parameter set was used. It would thus appear that pose
fidelity cannot be used to predict rank and thus whether
the model is suitable for prospective docking.
Table 1. Docking Successes with DOCK Blaster
a
Outcome Astex-85 Gold-114 DUD-38 PDB-9050
success 29 27 15 1398
ligand never
ranks well
44 67 21 6357
ligand fails
to dock
automatically
2 20 2 1295
aNumber of targets where fully automatic docking with DOCK
blaster is successful, as judged by both good pose fidelity (< 2.0 A ˚
RMSD) and rank (top 5%) versus about 100 property-matched
decoys.
Table 2. Docking Success Depends on Docking Parameters
a
parameter choice DOCK score ScreenScore FlexX PLP PMF
all 18 18 16 18 10
any 29 36 33 38 22
aSuccessisdefinedasligandwithin2A ˚ RMSDofthecrystalposeand
rank in the top 5% of about 100 property-matched decoys. Astex-85
benchmark. For instance, whereas 29 targets succeeded for pose fidelity
and rank using any of four parameter sets and the standard DOCK
scoring function, only 18 of these succeeded with all parameter sets.5716 Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 Irwin et al.
Wewerecuriousaboutwhetherligandrankwassensitiveto
the scoring function used. To explore this, we rescored the
ligand and all its decoys as docked using DOCK with four
widely used, different scoring functions (Table 2 and http://
data.docking.org/2009/RescoringTables.doc), in each case
without any change to the receptor or ligand structure. Three
ofthescoringfunctionsrankedtheligandsubstantiallyhigher
compared to the decoys, resulting in between 4 and 9 more
successes.OnlyPMFresultedinfewersuccessesthanDOCK.
GOLD-114 Benchmarking. Because we used the Astex-85
set to tune our protocol and parameter choices, we worried
about overfitting.
52 To control for protocol bias, we turned
to the GOLD-114 benchmark
15 for which we did not allow
ourselvestoadjusttheautomaticprocedureoritsparameters
in any way. A total of 75 targets were successfully sepa-
rated into ligand and receptor automatically from the PDB
code alone (Supporting Information Table S1), and a fur-
ther 19 cases (94 total) could be run if the ligand three letter
Figure 4. LigandsfromtheAstex-85benchmarksthatredockwithgoodposefidelityandgoodrank(top5%ofpropertymatcheddecoys)with
all parameter sets used. (A) Nuclear hormone receptors (B) kinases (C) other enzymes.
Figure 5. Ligands from the Astex-85 benchmarks that redock with good pose fidelity but poor rank compared to property-matched decoys.Article Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 5717
code was also specified. Of the 94 calculations that started
automatically, all but two yielded a docked pose and score
for the ligand. Of the 20 targets that failed to produce a
docked ligand, three failed during ligand identification and
separation, five failed to prepare the ligand for docking, and
12 tried but failed to dock and score the ligand.
We asked how well automatic docking could recapitulate
the crystal structure when the docking protocol could not be
modified.Ofthe92thatyieldedadockedandscoredligand,58
posed within 2 A ˚ rmsd of the crystal structure (Supporting
Information Table S2 and http://data.docking.org/2009/
GOLDTables.doc). All parameter sets performed nearly
equivalently, and no single one was as successful as combining
thebest result from allfour. Whenthedocked posewas within
2A ˚ rmsd, 27 of these also managed to rank in the top 5% of
about 100 property matched decoys (Table 1 and http://data.
docking.org/2009/GOLDTables.doc).
DUD Benchmarking. Worrying about depending on a
single positive control as the sole basis for judging docking
performance, we turned to a benchmark for which more
actives were available. We used DOCK Blaster to dock to
targets in the DUD-38 benchmark
27 for which the ligand
pose was crystallographically observed. All targets could be
handled by the parser and submitted to the DOCK Blaster
queue. One ligand failed to be converted to SMILES auto-
matically (1CKP), but the rest of the 37 targets completed
normally yielding a redocked and scored ligand.
We began by assessing performance as before using a
single crystallographic ligand and its automatically gener-
ated decoys, asking how well automatic docking could
recapitulate the crystal structure. Of the 37 protein-ligand
pairs that yielded a docked ligand score, 23 posed within 2 A ˚
rmsdofthecrystallographicligand(SupportingInformation
Table S2 and http://data.docking.org/2009/DUDTables.
doc). When the docked pose was within 2 A ˚ rmsd, 15 of
these also ranked the ligand in the top 5% of about 100
property matched decoys (Table 1 and http://data.docking.
org/2009/DUDTables.doc).
As part of DUD, these targets benefited from between 20
and 600 additional annotated actives and their correspond-
ing property-matched decoys with which to test DOCK
Blaster. We began by checking that the fully automatic
docking results using DOCK Blaster were at least compar-
able to the expert docking reported in the DUD paper
(Figure 9 and Supporting Information Table S3). If auto-
maticdockingwereconsistentlydifferentfromanexpert,the
conclusionsofthisstudycouldbeundermined.Forinstance,
an expert can experiment with the placement of specific
water molecules, modification of receptor parameters, or
docking parameters and do so repeatedly until the results
converge. Whereas fully automated docking often produced
results somewhat inferior to an expert, we thought it was
close in all but five cases.
A critical question was how predictive the single molecule
metric used thus far was of the multimolecule DUD metric
(Table 3 and http://data.docking.org/2009/). For simplicity
we rated each metric as “good” or “bad” to indicate whether
the docking results looked compelling enough to use for a
discovery project. For the single ligand metric, “good”
meant both pose fidelity within 2 A ˚ rmsd and rank strictly
in the top 5% of the property matched decoys. For the
multiligand (DUD) metric, “good” meant that either the
adjusted logAUC
53 was greater than 10, or that EF1, the
Figure 8. Plotofposefidelity(A ˚ ,rmsd)versus%rankcomparedto
about 100 property matched decoys (log scale). For Astex-85
benchmark. In each case, the parameter set that gave the best pose
fidelity was used.
Figure 7. Histogram and cumulative frequency of pose fidelity
(A ˚ , rmsd) using the best parameter set. Astex-85 benchmark.
Figure 6. Ligands from the Astex-85 benchmark that do not achieve good pose fidelity under any circumstances.5718 Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 Irwin et al.
fraction of ligands found by the first percentile, was greater
than 10%, or that EF5 was greater than 20%. Our results
show that in 26 of 36 or 72% of cases where automatic
docking completed normally, the single ligand metric of
docking success predicted the multiligand assessment. This
result allows us to deploy the single ligand metric as a
reasonable predictor of overall enrichment.
PDB Benchmarking. A common criticism of docking is
that it often seems to encounter unforeseen problems with
each new target, and correspondingly one never knows in
advance whether docking will “work”. Equipped with a
fully automated system and single-ligand based assessment
tools, we turned to a larger set of targets to investigate the
prevalence of situations that are not well handled by our
scripts. Of the 9050 eligible PDB targets submitted to the
parser, 7755 produced a docked ligand structure that could
be scored and ranked (Table 4). Of these, 3056 had the
ligand redock within 2 A ˚ rmsd of the crystal structure
(http://data.docking.org/2009/PDB3056.xls). About 100
property-matched decoys were generated automatically
for each ligand, docked, and used to calculate the rank of
the redocked ligand using each of four parameter sets. In
1 3 9 8o ft h e s ec a s e s ,t h el i g a n da l s os c o r e di nt h et o p5 % ,
representing 18% of the 7755 targets that were viable for
automatic docking.
Discussion
Recognizing the potential benefit of automated high
throughput docking to interpret the growing number of
protein structures, we have developed an automatic docking
Figure 9. Receiveroperatorcharacteristic(ROC)plotscomparingenrichmentbyDOCKBlaster(magenta)versusanexpert(darkblue) against
four targets fromthe DUD benchmark. (A) COX-2 (B) RXR alpha (C) ER-agonist(D) SAHH. Randomenrichment shown bya thin gray line.
Table3. CorrelationofDockingSuccessAssessmentbetweentheSingle
MoleculeMetric andMultipleMoleculeMetricfor the DUD-38Bench-
mark.
a
single molecule metric
multiple molecule
metric (DUD) good bad
good 12 6
bad 4 14
aSuccess for the single molecule metric has pose fidelity within 2 A ˚
RMSDandrankinthetop5%ofproperty-matcheddecoys.Successfor
the DUD metric is adjusted logAUC > 10 or EF1 > 10% or EF5 >
20%. Diagonal: 26. Off diagonal: 10. Automatic docking failure: 2.
Correlation: 72%.
Table 4. Attrition of PDB Structures Subjected to Fully Automated
Docking Using DOCK Blaster
a
count
as % of
previous row
ligand identified, DOCK
Blaster job started
9050
ligand docked and scored 7755 86
pose good (<2 A ˚ rmsd) 3056 39
may be useful prospectively
(<2 A ˚ rmsd; rank top 5%)
1398 46
aAug 1, 2008 version, of the PDB having 52000 x-ray crystal
structures in total.Article Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 5719
system and assessed its performance in retrospective tests.
Five results emerge from this study. First, DOCK Blaster, an
automaticdockingsystem,isnowavailableforfreepublicuse
and can produce useful results starting with as little as a PDB
code. Second, useful results as judged by good pose fidelity
and rank compared to property matched decoys were
achieved in around 30% of cases against common bench-
marks. Third, surprisingly, pose fidelity as measured by rmsd
isnot predictiveof rankandis thereforenot a useful metricof
dockingsuccessbyitself.
54Fourth,asingleligandmetricusing
the crystallographic ligand is predictive of the multiligand
enrichment over property-matched decoys 72% of the time.
Finally, DOCK Blaster has been deployed on a large scale
andproducedscreeningresultsthatdeservefurtherconsidera-
tion for experimental testing in 1398 of 7755 cases drawn
from the PDB.
The result that will have perhaps the greatest pragmatic
impact is the creation of the DOCK Blaster server itself.
BecauseDOCKBlastercanstartfromaslittleasaPDBcode,
can produce results like an expert in some cases, and can self-
evaluate,itissuitableforusebynonexpertsandforlarge-scale
experiments. When docking performs poorly or fails comple-
tely,thiscanusuallybededucedautomaticallyfromfailuresin
pose fidelity and rank-to-decoys statistics. Thus the prospec-
tive user of this system can estimate whether the docking
results are likely to be useful for discovery, should be ignored
completely, or perhaps fall somewhere in between. Of course,
any system of this complexity is bound to have flaws, and
some projects will simply not work. Still, it is our hope that
DOCKBlasterwillbeusefulfornonexperts,loweringbarriers
to entry to the field.
PosefidelityusingDOCKBlasterinretrospectivestudiesis
notquiteasgoodaswhenperformedbyanexpert.Ourblack-
box system achieves pose fidelity within 2 A ˚ rmsd for about
50-60% of targets, compared to 70-80% for expert-guided
docking. Perhaps surprisingly, pose fidelity as measured by
rmsd deviation did not correlate at all with rank. For enrich-
ment, again our results are not quite as good as reported in
otheravailablestudies.Thisshouldbeunsurprising,however,
becauseexpertsareatlibertytomanuallycuratesites,ligands,
and protocols to maximize performance. Useful results, i.e.,
good pose fidelity and good enrichment, were obtained in
25-40% of benchmark cases. The success rates for Astex-85
was 29 out of 85, for GOLD-114 it was 27 out of 114, and for
DUD-38 15 out of 38 were successful for both pose-fidelity
and enrichment. Whereas this might not seem a very high
success rate, no study has ever held itself to such a stringent
standardbefore,andthiswasonlypossiblewithanautomated
program.
As a basis for performance assessment, a single ligand with
generated property-matched decoys predicts the multiligand
assessment three times out of four. Because only one ligand is
needed, this has significant advantages for automation, en-
abling automatic self-assessment of docking results, which
wouldbe impracticalif a list of actives hadtobeassembledto
benchmarkeachtarget.Thecorrelationwaslargelyinsensitive
to the precise cutoffs used to characterize docking success or
to which scoring function was used. Of course, this result is
provisional,asitisbasedontheDUD-38benchmarkandmay
be revised as larger benchmarks appear.
DOCK Blaster has been deployed on a near-proteome
scale, and produced useful results for 1398 of 7755 targets or
18% of the PDB structures that were amenable to this
method. Because docking can recapitulate what is already
knownaboutthesiteinthesecases,thereisareasonablehope
for prospectivedocking tosuggestligandsthatmightactually
bind. Many of these problems were previously known
(conformational sampling, ligand representation, structural
waters), but their prevalence is now better quantified.
There is a critical need to find new small molecule reagents
for biology. At the same time, a rapidly growing backlog of
uninterpreted structures has accumulated in the PDB. Yet in
an age of plentiful target structures, freely available small
molecule databases, many sophisticated docking programs,
and fast computers to run them on, many biologically or-
iented investigators still find docking for ligand discovery
daunting. We have developed DOCK Blaster to help non-
specialists find new reagents for biology without the need for
an expert. As for experts, DOCK Blaster does not produce
compelling results for all targets. But for the nearly 20% of
targets we tried where it does produce results deserving of
further investigation, DOCK Blaster offers a way to auto-
matically leverage structure for ligand discovery.
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